Navigation Links
EastBridge Investment Group and CBMG attended SeeThruEquity Investor Conference in New York
Date:12/12/2012

PHOENIX, Dec. 12, 2012 /PRNewswire/ -- EastBridge Investment Group Corporation (OTCQB: EBIG), a provider of financial consulting services to companies in Asia ("EastBridge") today announced management teams of EastBridge and Cellular BioMedicine Group Corp have attended an investor conference held in New York city on Dec 04, 2012, organized by SeeThruEquity.

Keith Wong, CEO of EastBridge, commented, "Led by a team of seasoned management personnel and scientists, CBMG has developed cellular medicine technologies featuring autologous and allogeneic platforms. In collaboration with multiple Chinese AAA hospitals, CBMG maintains a pipeline of clinical trials including treatments for knee osteoarthritis, rheumatoid arthritis and lupus disease. Its cancer treatment therapies under development feature cytokine-induced killer (CIK) cells.  In addition, it is also working on a tumor cell targeted dendritic cells (TC-DC) clinical trial on liver cancer."

Steve Liu, CEO of CBMG, added, "We are very happy to see the response from the conference attendees to our presentation. Overall, we believe that our multiple platforms of stem cell based future products offer CBMG an engine for future growth."

About Cellular Biomedicine Group
Cellular Biomedicine Group, Ltd. is in the development of cell therapies for the treatment of certain cancer and degenerative diseases. Our developmental stem cell, progenitor cell, and immune cell projects are the result of collaborative research and development between scientists and doctors from the U.S. and China. Its flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com

About EastBridge
EastBridge Investment Group focuses on high-growth companies in Asia and in the United States, offering assistance with al
'/>"/>

SOURCE EastBridge Investment Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
2. Life Technologies to Present at Upcoming Investment Conferences in February
3. New investment aims to establish the UK as a global graphene research hub
4. Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
5. City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters
6. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
7. Regenerative Sciences Receives $2M Investment for Orthopedic Stem Cell Initiatives
8. Foundation Venture Capital Group Makes Eighth Start-Up Investment
9. Israeli Ministry of Finance Hosts Israel Investment, Innovation and Trade Forum in New York
10. David Lichtenstein: Biotechnology is Rich Area for Investment
11. Kansas Bioscience Authority Approves $700,000 in Investments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Advance Nanotech, Inc.,(OTC Bulletin Board: AVNA), announced ... received an order from SELEX GALILEO,totaling $629,000. SELEX ... Aerospace and Defense organizations, is a leader in,surveillance, ... This contract marks the third order in 18 ...
... 24 Sun Pharmaceutical,Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP ... Dr. Barrie Levitt, Chairman of the Board,of Directors of ... to Dr. Levitt,s letter of June 19, 2008 to ... Pharma and the Initiating,Motion filed by Taro in the ...
... Knowledge Enterprises,Inc. announced today that attendance from orthopaedic ... Technology Exposition and,Conference (OMTEC) was up more than ... on the initial feedback from attendees and exhibitors,alike, ... secured a permanent position,in the orthopaedic industry as ...
Cached Biology Technology:Advance Nanotech's Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo 2Advance Nanotech's Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo 3Advance Nanotech's Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo 4Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 2Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 3Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 4Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 5Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 6Sun Pharmaceutical Sends Second Letter to Taro Pharmaceutical Regarding Taro's Irish Subsidiary 7OMTEC 2008 Boasts Record Attendance and Secures Premier Position as Must-attend for Orthopaedic Companies 2
(Date:4/15/2014)... In a study of nearly 1,000 mother-child pairs, ... found that prenatal exposure to selective serotonin reuptake ... anxiety and other disorders, was associated with autism ... boys. The study, published in the online edition ... samples of ASD and DD cases, and population-based ...
(Date:4/15/2014)... study the deadliest infectious diseases recognized the contributions of ... the University of Texas Medical Branch, with a Lifetime ... Filoviruses. The filoviruses include Ebola and Marburg viruses that ... infected. The current outbreak of Ebola virus raging in ... far. , "This award represents the culmination of ...
(Date:4/15/2014)... CAMBRIDGE, MA -- Delivering chemotherapy drugs in nanoparticle form ... directly to the tumors. In recent years, scientists have ... but it has been difficult to design particles ... precise ratio. , Now MIT chemists have devised a ... easier to include three or more different drugs. In ...
Breaking Biology News(10 mins):Study: SSRI use during pregnancy associated with autism and developmental delays in boys 2International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3
... step closer to understanding what drives tumor metastasis, as ... can slow their own growth. In a recent ... the American Association for Cancer Research, Ral A. Ruggiero, ... medicine at the National Academy of Medicine in Buenos ...
... from preclinical studies in a skin cancer model ... first-generation BRAF inhibitors used in combination with an ... potential to prevent drug-induced skin lesions in BRAF ... studies, presented at the AACR-NCI-EORTC International Conference: Molecular ...
... pollution and other particulate matter in the atmosphere can strongly ... regions or seasons, while increasing rain, snowfall and the intensity ... new study by a University of Maryland-led team of researchers. ... how aerosols -- soot, dust and other small particles in ...
Cached Biology News:New approaches may prevent certain side effects in BRAF mutation-positive melanoma 2Rising air pollution worsens drought, flooding, UMD-led study shows 2Rising air pollution worsens drought, flooding, UMD-led study shows 3Rising air pollution worsens drought, flooding, UMD-led study shows 4
... Jouan RCT series of refrigerated cold traps ... trapping of low volatility/aqueous solvents or high ... and other vacuum concentrators/centrifugal evaporators. Also used ... systems such as used in electron microscopes. ...
... Vapor Trap is specifically designed for ... such as DMSO and DMF in ... temperature refrigeration system set at -5 ... for DMSO, while completely eliminating the ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
Thermo Forma provides an array of accessory Racks for the Cryo/CryoPlus 16" Diameter storage system. To maximise inventory capacity a Jumbo Arrowhead configuration is recommended. You may choose betw...
Biology Products: